Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain

• Status: Completed
• Trial end date: 2018-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study to evaluated Long term outcome after serial Lidocaine infusion when compared with placebo in peripheral neuropathic pain patients in acute stage (less than 6 months) at 3 months after first time of infusion

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mahidol University
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Peripheral neuropathic pain from peripheral nerve injury within 6 months after injury

• Well understand to Thai language in writing or listening

Exclusion Criteria:

• Underlying Heart disease or Arrhythmia

• Allergy to lidocaine, Gabapentin, Carbamazepine, tramadol

• History of epilepsy

• History of lidocaine used

• Underlying Psychiatric disease

• History of drug abuse

• Pregnancy and nursing